Clinical Trial Update: Cytokine Inhibition in Chronic Fatigue Syndrome Patients [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial update on cytokine inhibition for Chronic Fatigue Syndrome reports that the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue Syndrome

Snippet

Sponsor: Radboud University Medical Center | Conditions: Chronic Fatigue Syndrome | Phase 2, Phase 3 | Status: COMPLETED